TROAP promotes esophageal squamous cell carcinoma progression via the PI3K/AKT pathway
This study revealed that TROAP promotes ESCC progression via activating PI3K/AKT pathway, suggesting that TROAP might be a promising therapeutic target for ESCC.
Authors
- Mingyuan Du (ORCID: https://orcid.org/0009-0004-0625-2601)
- Chuanyin Li (ORCID: https://orcid.org/0000-0002-8007-6878)
- Liqiang Shi
- Cong Yang (ORCID: https://orcid.org/0000-0001-5860-0904)
- Dong Dong (ORCID: https://orcid.org/0000-0003-1998-0208)
- Yaxin Wang (ORCID: https://orcid.org/0009-0003-2540-6437)
- Hecheng Li (ORCID: https://orcid.org/0000-0001-8069-6033)
- Yichao Han (ORCID: https://orcid.org/0000-0002-9691-3028)
- Yajie Zhang (ORCID: https://orcid.org/0000-0002-3008-8897)
- Yun Yang (ORCID: https://orcid.org/0000-0001-5482-5997)
Institutions
- Tongji University (CN)
- Ruijin Hospital (CN)
- Zhejiang Cancer Hospital (CN)
- Shanghai Tenth People's Hospital (CN)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- Journal of Cancer Research and Clinical Oncology
- Published
- 2025-04-19
- DOI
- https://doi.org/10.1007/s00432-025-06200-2
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Shanghai Municipal Health Commission
- National Natural Science Foundation of China
- Shanghai Jiao Tong University
- National Key Research and Development Program of China